Clinical Studies

    Nicotine Pharmacokinetic and Pharmacodynamics Profile, Safety and Tolerability of P3L

    First posted
    Aug 25, 2015
    Identifier
    NCT02532374
    Topic
    Official Title

    A Single-center, Open-label, Ascending Nicotine Levels Study to Investigate the Nicotine Pharmacokinetic and Pharmacodynamics Profiles, Safety and Tolerability of P3L in Smoking Healthy Subjects in Relation to Nicorette® Inhalator

    Brief Summary

    The purpose of this study is to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD, i.e., subjective effects) profiles, and the safety and tolerability of the nicotine-containing aerosol delivered by Platform 3 Liquid (P3L) system at three different nicotine levels in smoking healthy subjects in relation to Nicorette® inhalator.

    Summary

    Recruitment: Completed

    Study Results: Available

    Enrollment: 16

    Study Type: Interventional

    Other IDs: P3L-PK-01-NZ